Instituto Gulbenkian de Ciencia is located in the Oerias about 20km from Lisbon, Portugal. It was formed to study and research the genetic basis of development, evolution of complex systems, the genetics of complex human disease, and includes privileging organism centered approaches in experimental models that includes, plants, yeast, flies, and mice for the purpose of studying human disease. The BioInformatics, Cell Imaging, and Chemical and Biological Technology institutes are among the research centers of IGC Gulbenkian. It is the home to post-doctoral fellows, scientists working on individual research programs.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A group of scientists from Instituto Gulbenkian de Ciência (IGC), led by Luís Moita, discovered that a hormone that has been pointed out as a treatment for obesity reduces the resistance to infection caused by bacteria ...
Jun 22, 2020
0
96
Despite intensive research effort, the process of metastasis, which allows carcinoma cells to leave the tumor of origin, to migrate and to grow tumors within other organs, is still the leading cause of mortality for cancer ...
Mar 31, 2020
0
0
The diversity of bacteria in the human gut is an important biomarker of health, influences multiple diseases such as obesity and inflammatory bowel diseases and affects various treatments. How its diversity is maintained ...
Mar 12, 2020
0
2
The prevalence of obesity, a disease considered a serious public health problem, is increasing globally. In Portugal, almost half of the population is overweight and close to one million adults suffer from obesity. Known ...
Jan 10, 2020
0
2
"Genomics of a Mock Outbreak" was a stress test on the ability to identify and characterize multidrug-resistant bacteria isolated from patients and the hospital environment. The results, released on European Antibiotic Awareness ...
Nov 21, 2019
0
0
A new study from researchers of CEDOC-NOVA Medical School|Faculdade de Ciências Médicas and Instituto Gulbenkian de Ciência, led by Maria Paula Macedo and Carlos Penha-Gonçalves, respectively, showed that a molecule CD26/DPP-4 ...
Sep 26, 2018
0
0
One of the major therapeutic targets for inflammatory diseases is the inflammation-inducing molecule TNF. However, excess levels of TNF cause side effects and can lead to diseases. In a study now published in eLIFE, the research ...
Jul 27, 2018
0
3
Glioblastoma is the most severe form of brain cancer in adults. The aggressiveness of this cancer is largely due to its ability to invade surrounding brain tissue, making the tumor difficult to remove by surgery. Now, a research ...
Jun 14, 2018
0
1
A research team led by Monica Bettencourt Dias, from Instituto Gulbenkian de Ciencia (IGC, Portugal), has discovered important features of cancer cells that may help clinicians fighting cancer. The researchers observed that ...
Mar 28, 2018
0
29
In a recent study published in Cell Reports, a research team led by Colin Adrain, from the Instituto Gulbenkian de Ciência (IGC, Portugal), discovered the mechanism that controls the release of important molecules that trigger ...
Nov 02, 2017
0
0
